Join us for an educational session with Dr. Michael Rogawski.
Dr. Michael Rogawski, a professor and physician at UC Davis Health, will explain the Clinical presentation of GABR Variants and current treatments.
He has been elected a fellow of the National Academy of Inventors (NAI), the highest professional distinction for academic inventors. His inventions in drug discovery and development, particularly in the field of neuropharmacology, have led to significant advancements in treating epilepsy and neuropsychiatric conditions.
Dr. Rogawski’s election as an NAI fellow recognizes his prolific spirit of innovation and contributions to improving the quality of life through groundbreaking inventions. Notable achievements include the development of epilepsy drug perampanel (Fycompa®) and brexanolone (Zulresso™), the first FDA-approved drug for postpartum depression. His work reflects a dedication to translational research and collaboration within the scientific community.
Join Cure GABA-A and Dr. Michael Rogawski on Feb 27, 2024 12:00 PM PST for an educational session. For more details, contact us on our socials or email: monica@cureGABAa.com.
Can’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience.
Join us in our collective mission to improve the lives of patients with GABA-A Variants and work toward a brighter future.